Development and Validation of a Novel Immune-Related Prognostic Model in Hepatocellular Carcinoma

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-020-02255-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Development and Validation of a Tool to Assess Hepatocellular Carcinoma Knowledge Among Hepatocellular Carcinoma Patients in Taiwan

Open Journal of Nursing
2020English

A Novel Prognostic Scoring Model Based on Albumin and Γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis

Cancer Management and Research
Oncology
2019English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Reply: A Morpho-Molecular Prognostic Model for Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Development and Validation of a Prognostic Score Predicting Recurrence in Resected Combined Hepatocellular Cholangiocarcinoma

Cancer Management and Research
Oncology
2019English

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients With Hepatocellular Carcinoma Underwent Hepatectomy

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Preoperative Risk Stratification for Early Recurrence of HBV-related Hepatocellular Carcinoma After Deceased Donor Liver Transplantation: A Five-Eight Model Development and Validation

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy